A B S T R A C T Human neutrophils stimulated with phorbol myristate acetate were able to destroy suspensions or monolayers of cultured human endothelial cells. Neutrophil-mediated cytotoxicity was related to phorbol myristate acetate concentration, time of incubation and neutrophil number. Cytolysis was prevented by the addition of catalase, while superoxide dismutase had no effect on cytotoxicity. The addition of the heme-enzyme inhibitors, azide or cyanide, markedly stimulated neutrophil-mediated damage while exogenous myeloperoxidase failed to stimulate cytolysis. Neutrophils isolated from patients with chronic granulomatous disease did not destroy the endothelial cell targets while myeloperoxidase-deficient neutrophils successfully mediated cytotoxicity. Endothelial cell damage mediated by the myeloperoxidase deficient cells was also inhibited by catalase but not superoxide dismutase. The addition of purified myeloperoxidase to the deficient cells did not stimulate cytotoxicity. Glucose-glucose oxidase, an enzyme system capable of generating hydrogen peroxide, could replace the neutrophil as the cytotoxic mediator. The addition of myeloperoxidase at low concentrations of glucose oxidase did not increase cytolysis, but at the higher concentrations of glucose oxidase it stimulated cytotoxicity. The destruction of endothelial cells by the glucose oxidase-myeloperoxidase system was inhibited by the addition of hypochlorous acid scavengers. In contrast, neutrophil-mediated cytolysis was not effectively inhibited by the hypochlorous acid scavengers. Based on these observations, we propose that human neutrophils can destroy cultured human endothelial cells by generating cytotoxic quantities of hydrogen peroxide. INTRODUCTION Intact endothelial cell metabolism and functional activity plays an integral role in maintaining vascular integrity (1) (2) (3) . Injury of the endothelium appears to be an important step in the pathogenesis of immune or infection mediated vasculitides and atherosclerosis (1) (2) (3) . The human neutrophil possesses a powerful cytotoxic armamentarium (4, 5) and its intravascular activation could lead to endothelial cell injury and death.
Neutrophils ingesting particles, adhering to immune coated surfaces, or responding to soluble stimuli undergo a burst in metabolic activity, discharge lysosomal components, and generate reactive oxygen metabolites (4, 5) . In order to examine the destructive potential of the intact leukocyte, we have used a model system in which human neutrophils are exposed to the soluble stimulant, phorbol myristate acetate (PMA),1 and incubated with a target cell population (6) (7) (8) (9) . In earlier studies, this model system has allowed us to demonstrate two distinct mechanisms of neutrophilmediated cytotoxicity (6) (7) (8) (9) . Erythrocyte targets were lysed by a reaction between superoxide anion (O2) and oxy-hemoglobin, whereas tumor cells were destroyed by an oxidant generated from the hydrogen peroxide (H202)-myeloperoxidase-halide system (8, 9) . In this study we have examined the ability of PMAstimulated neutrophils to damage cultured human endothelial cells and have identified H202 as the cytotoxic mediator.
METHODS
Neutrophil preparation. Human neutrophils were obtained from heparinized venous blood of normal volunteers or patients with chronic granulomatous disease or myeloperoxidase deficiency. Patients with chronic granulomatous disease were identified by Dr. J. Silva (University Hospital, Ann Arbor, Mich.). An adult with myeloperoxidase deficiency was identified and blood generously provided by R. K. Root (Yale-New Haven Hospital, New Haven, Conn.). Leukocytes were isolated by Ficoll-Hypaque density centrifugationi and dextran sedimentation as previously described (10 In selected experiments performed with endothelial cell monolayers, cytolysis was determined both by 51Cr release and direct cell counts. At the end of the incubation period, a portion of the supernate was removed for 5'Cr release and the endothelial cells removed by treatment with 0.1% collagenase and 0.01% EDTA for 10 min at 37°C. The endothelial cells were then counted on a hemacytometer by light and phase-contrast microscopy.
H202 assayl. The quantitation of H202 generated by netitrophils or glucose oxidase was determined by the method of Thurman et al. (17) . Glucose oxidase or PMA-stimulated neutrophils (0.5-2.0 x 105) were incubated with 1 mM azide in a final volume of 1 ml in EBSS. At various times the reaction was terminated by the addition of 0.1 ml trichloroacetic acid (50% wt/vol). The samples were centrifuged (500 g, 10 min) and 0.2 ml of 10 mM ferrous ammonium sulfate and 0.1 ml of 2.5 M potassium thiocyanate (both from Fisher Scientific Co.) added to the supernate. The adsorption ofthe ferrithiocyanate complex was measured at 480 nm and compared to a standard curve generated from dilutions of concentration H202. The H202 concentration was calculated from the absorbance at 230 nm assuming an extinction coefficient of 81 MI-1 cm-' (18).
RESULTS
Neutro phil-mediated endothelial cell destruction.
As summarized in Table I , PMA-stimulated neutrophils were capable of destroying either suspensions or monolayers of human endothelial cells. Neither PMA nor neutrophils alone mediated significant cytotoxicity. Maximal cytolysis was obtained with a PMA dose of 10 ng/ml (data not shown). Fig. 1 illustrates the relationship of neutrophil number to endothelial cell destruction. Significant 51Cr release was seen with as few as 25,000 neutrophils, i.e., an effector to target cell ratio of 1.25:1. The time-course of 5'Cr release is shown in Fig. 2 with maximal release occurring between 4 and 6 h. Cytotoxicity was also determined with endothelial cell monolayers by direct hemacytometer counts of the cells remaining after a 6-h incubation. These results did not differ from those obtained (6) (7) (8) (9) . In order to characterize the possible role of 02 or H202 in the cytotoxic event, experiments were performed in the presence of superoxide dismutase or catalase. Superoxide dismutase lowers the 02 concentration, whereas catalase degrades H202. As shown in Fig. 3 , superoxide dismutase had no inhibitory effect while catalase almost completely prevented cytotoxicity. Heat-inactivated calalase failed to inhibit endothelial cell cytolysis (94±5% of control cytotoxicity, n = 4). The addition of catalase to the assay system 60 min after the start of the incubation had no inhibitory effect on cytolysis. Thus, H202 appears to play a key role in this cytotoxic event during the 1st h of incubation. (4, 5) . To determine the possible role of this enzyme in neutrophil-mediated cytotoxicity, experiments were performed in the presence of the heme-enzyme inhibitors azide or cyanide. As shown in Fig. 3 , both of these agents markedly stimulated cytotoxicity. Neither of the inhibitors alone had any effect on 51Cr release. Although PMA has been reported to be a weak stimulus for the release of myeloperoxidase (19, 20) , the addition of exogenous myeloperoxidase failed to stimulate cytotoxicity (Fig. 3) . H202 is also capable of reacting with a variety of metal complexes to form the extremely reactive hydroxyl radical (OH') (21) . The addition of high concentrations of OH scavengers (20 mM ethanol or mannitol) failed to inhibit neutrophil-mediated cytotoxicity (89+5% and 92+4% of control, respectively, n = 3). Thus, no role could be demonstrated for this species under the conditions used.
Further characterization of the mechanism of cytotoxicity was determined with neutrophils isolated from patients with chronic granulomatous disease or hereditary myeloperoxidase deficiency. Chronic granulomatous disease neutrophils discharge lysosomal components, but are incapable of generating oxygen metabolites while myeloperoxidase-deficient cells can generate oxygen metabolites but lack myeloperoxidase (4, 5). The chronic granulomatous disease neutrophils were incapable of mediating cytotoxicity, whereas myeloperoxidase-deficient cells successfully destroyed the endothelial cell targets (Fig. 4) . Experiments designed to determine the mechanism of cytotoxicity utilized by the myeloperoxidase deficient cells are shown in Fig. 5 . Although superoxide dismutase had no inhibitory effect, catalase effectively inhibited cytolysis. The addition of azide enhanced cytotoxicity while exogenous myeloperoxidase failed to stimulate cytolysis (Fig. 5) . In addition, OH scavengers were ineffective in preventing endothelial cell destruction (data not shown). Thus, it appears that both normal and myeloperoxidase deficient cells can destroy endothelial cell targets by a mechanism dependent on H202.
Glucose-glucose oxidase-mediated endothelial cell destruction. In order to test the cytotoxic potential of H202 alone, a cell-free model system was used. Glucose oxidase divalently reduced 02 directly to H202 at a slow continuous rate and was tested for its ability to mediate cytotoxicity. Fig. 6 illustrates the sensitivity of a suspension of endothelial cells to the glucose oxidase system. Cytotoxicity could be demonstrated with as little as 0.66 mU of enzyme. When 1.32 mU of glucose oxidase was added, it mediated 65% cytotoxicity while generating 12±5 nmol of H202 (n = 4). This compares to the ability of 2 stimulated neutrophils to produce 20±5 nmol of H202 (n = 4). Endothelial cell destruction was effectively prevented by exogenous catalase (10 ,g/ml) and was not stimulated by the addition of 1 mM azide. Identical results were obtained with endothelial cell monolayers exposed to the glucose oxidase system. In contrast, CEM targets were insensitive to H202 since none of the doses of glucose oxidase used produced cytolysis (Fig. 6) .
Role of the myeloperoxidase system in endothelial cell destruction. Thus far, we have demonstrated the myeloperoxidase-deficient neutrophils or normal neutrophils incubated with heme enzyme inhibitors are capable of destroying endothelial cells. Although these results demonstrate that H202 can mediate endothelial cell cytolysis, these data do not rule out an additional role for the myeloperoxidase system in the normal neutrophils. To explore the sensitivity of endothelial cells to myeloperoxidase-dependent cytolysis, myeloperoxidase was added to the glucose oxidase system. At high doses of glucose oxidase, myeloperoxidase enhanced endothelial cell lysis but at the lower doses of glucose oxidase the addition of myeloperoxidase did not stimulate cytotoxicity (Fig. 6) . These results contrast with those obtained with the CEM targets where cytolysis was totally dependent on the addition of myeloperoxidase (Fig. 6) .
The H202-myeloperoxidase-Cl-system is capable of generating the powerful oxidant hypochlorous acid (HOCG) (22) (23) (24) . HOCG is known to react rapidly with amines, amides, or sulfhydryl groups and can destroy a variety of biological targets including bacteria and tumor cells (5, 8, 25, 26) . If HOCG plays a role in endothelial cell cytotoxicity, then compounds known to scavenge the species should protect the cell from damage (8, 25, 26) . When serine, valine, or isoleucine (20 mM), compounds known to react rapidly with HOCG, were added to a glucose oxidase (2.6 mU) myeloperoxidase (16 mU) system endothelial cell cytotoxicity was reduced to zero percent (n = 4). The addition of these amino acids to the glucose oxidase system did not inhibit cytotoxicity (n = 4). Thus, while H202-dependent destruction is not affected by the amino acids, myeloperoxidase-mediated damage can be prevented by these compounds.
In order to investigate the potential role of the myeloperoxidase system in neutrophil-mediated endothelial cell destruction, experiments were performed in the presence of these HOCG scavengers. In eight experiments, amino acids that were capable of completely protecting endothelial cells from myeloperoxidase-dependent damage produced modest inhibition of neutrophil-mediated cytolysis (Table II) . In contrast, neutrophil-mediated CEM destruction, an event dependent on H202 and myeloperoxidase (8), was consistently inhibited by these same HOCG (6) (7) (8) (9) . The human vascular endothelium provides a particularly interesting target since intravascular activation of the neutrophil would expose the endothelium to a noxious environment. Possible in vivo activators of the neutrophil could include aggregated immunoglobulin, activated complement components, immune complexes, or bacterial peptides (4, 5) . All of these agents can stimulate the neutrophil to discharge lysosomal enzymes and generate oxygen metabolites. In this study, we have used the soluble agent, PMA, as a model stimulus of leukocyte oxidative metabolism. Although PMA is not a physiological stimulus, it is capable of stimulating all aspects of oxidative metabolism normally associated with phagocytosis (27) .
In this report, we have demonstrated that PMAstimulated neutrophils are capable of destroying suspensions or monolayers ofcultured, human endothelial cells. Cytotoxicity was inhibited by catalase but not by superoxide dismutase. Thus, while 02 itself does not appear cytotoxic, the product of its dismutation, H202, plays a key role in the cytotoxic event. The importance of H202 alone in endothelial cell destruction is reinforced by four additional observations. First, azide or cyanide, two potent heme-enzyme inhibitors, markedly stimulated neutrophil-mediated cytotoxicity. Either of these agents could block endothelial cell catalase or inhibit mitochondrial metabolism and increase the sensitivity of the cell to H202, but the addition of the inhibitors to the glucose oxidase system did not increase cytotoxicity. It appears that the stimulation of cytotoxicity in the neutrophil system reflects the increased availability of H202 secondary to the inhibition of neutrophil catalase and/or myeloperoxidase. Second, neutrophils isolated from patients with chronic granulomatous disease that are incapable ofgenerating oxygen metabolites did not destroy endothelial cells in this system. Third, cells isolated from a patient with myeloperoxidase deficiency mediated significant endothelial cell cytotoxicity. Absence of this enzyme is associated with impaired bactericidal (28) , fungicidal (29) and possibly tumoricidal (30) activity, but these cells were efficient in mediating endothelial cell cytotoxicity. Although only one patient was tested, it appears that the myeloperoxidasedeficient cells were even more cytotoxic than normal neutrophils at the low effector to target cell ratios.
Myeloperoxidase deficient cells generate more 02--, H202 and possibly OH than normal neutrophils (31, 32) but appear to destroy endothelial cells by H202 alone. The utilization of these neutrophils clearly demonstrate the cytotoxic potential of cell-derived H202. Finally, the sensitivity of endothelial cells to H202 alone was demonstrated by using the glucose oxidase system. Less than 1 mU of the enzyme system was capable of mediating significant endothelial cell destruction. Clark and Klebanoff have routinely used high doses of glucose oxidase with erythrocyte, leukocyte, and tumor cell targets without reporting cytotoxicity (33) (34) (35) . In our experiments CEM were resistant to even higher doses of glucose oxidase than those used by Klebanoff and co-workers.2 Recently, Bass and Szejda reported that Trichinella larvae were highly sensitive to H202 based on the cytotoxic effect of 5 mU of glucose oxidase in a 6-h assay (36) . Apparently the endothelial cell is another example ofa cell population with extreme sensitivity to H202.
Although both myeloperoxidase-deficient neutrophils and the glucose oxidase system could destroy endothelial cells by generating H202, this does not limit the normal neutrophil to the utilization of H202 as the sole cytotoxic agent. The addition of hemeenzyme inhibitors to normal neutrophils allowed us to demonstrate the sensitivity of the endothelial cell to H202 but masked the potential cytotoxicity of the myeloperoxidase system. Indeed, PMA-stimulated neutrophils can clearly destroy other target cells by generating H202 and releasing myeloperoxidase (8, 37) . To investigate the sensitivity of the endothelial cells to the myeloperoxidase system, experiments were initially performed with the glucose-oxidase-myeloperoxidase model. Despite the ability of H202 alone to destroy endothelial cells, the addition of myeloperoxidase significantly stimulated cytolysis. The destructive role of myeloperoxidase-derived HOC1 in the cytotoxic event was reinforced by the protective effect of the amino acids in the model system. Based on the sensitivity of the endothelial cells to the myeloperoxidase system and the ability of PMA-stimulated neutrophils to destroy other target cells by this mechanism, we were surprised by two observations. First, exogenous myeloperoxidase inhibited endothelial cell cytotoxicity mediated by both normal and myeloperoxidase-deficient neutrophils. Second, amino acids that were extremely effective in preventing glucose oxidase-myeloperoxidase-mediated cytotoxicity failed to strongly inhibit neutrophil-mediated destruction. The amino acids may have encountered difficulty in gaining access to the endothelial cell-neutrophil interface but this seems unlikely since these scavengers protected tumor cells from neutrophil-mediated cytotoxicity in an identical system. Serine alone significantly inhibited endothelial cell destruction by the neutrophils but the inability of the other scavengers to prevent cytolysis makes interpretation of its effect difficult. Although these results appear paradoxical, it is interesting to note that (a) at low concentrations of glucose oxidase the addition of myeloperoxidase failed to stimulate endothelial cell destruction, and (b) these same doses of glucose oxidase and myeloperoxidase were more effective in destroying the tumor cells. It appears that the H202-resistant tumor cell is more sensitive to HOC1 than the endothelial cell. Thus, despite being exposed to neutrophil-derived H202 and myeloperoxidase, the endothelial cell is primarily sensitive to H202 and not myeloperoxidase-derived products. Alternatively, we cannot rule out the possibility that the less reactive species, H202, is able to reach the endothelial cell at a higher concentration than the more reactive HOCI.
Sacks et al. (38) also studied the effect of neutrophilderived oxygen metabolites in endothelial cell injury. They demonstrated that human neutrophils stimulated with C5a were capable of destroying monolayers of umbilical vein endothelial cells. In their report, neutrophils mediated 5-10% damage as assessed by 5 'Cr release and 20-30% damage by viability staining after a 90-min incubation. Endothelial cell destruction was partially inhibited by catalase while superoxide dismutase had no effect but, the addition of both enzymes effectively inhibited 5'Cr release. In addition, neutro-phils isolated from a patient with chronic granulomatosus disease were capable of mediating a cytotoxic response 50% as effective as that obtained with control neutrophils. The authors concluded that C5a stimulated neutrophils destroyed endothelial cells by a mechanism dependent on an uncharacterized oxygen radical. Although their conclusions differ from our own, H202 might be the mediator of cytotoxicity in the C5a system. The enhanced inhibition of cytotoxicity seen with catalase and superoxide dismutase could be secondary to the prevention of catalase inactivation by 2 -(39), but we cannot rule out the possibility that different cytotoxic mechanisms may be operative with different stimuli. We attempted to use opsonized zymosan as another stimulus of leukocyte metabolism but it failed to mediate cytotoxicity. The addition of unopsonized zymosan to PMA-stimulated neutrophils completely inhibited endothelial cell cytotoxicity, probably by providing an additional oxidizeable substrate. PMA has the advantage of being an extremely potent stimulus that does not introduce large quantities of competing substrate at the effector-target cell interface.
Nathan et al. (40) also used PMA as a pharmacologic trigger with a murine macrophage model system. They reported that PMA-stimulated murine macrophages could destroy a variety of human and murine cell lines by a mechanism dependent on H202 alone. These results contrast with our observations on the mechanisms operable in neutrophil-mediated destruction of erythrocytes and tumor cells (6) (7) (8) (9) . In addition, Clark and Klebanoff recently demonstrated the ability of neutrophil-derived H202 to initiate a platelet release reaction (41) . In contrast with our studies, the myeloperoxidase-deficient neutrophils did not mediate the release reaction and the effect of H202 was only seen in the presence of heme enzyme inhibitors. Thus far, the endothelial cell is the only target that we have identified as sensitive to leukocyte-derived H202. Apparently, the selection of the effector cell, target cell and stimulus all play an important role in the determination of the mechanism of cytotoxicity.
Although caution should be exercised in extending the observations made with cultured venous endothelial cells of fetal origin, it is interesting to speculate on the possible sensitivity to the adult vascular endothelium. Wall et al. (42) have recently suggested that homocysteine-induced atherosclerosis might be due to H202 generated from the autooxidizing drug. In addition, it has long been appreciated that the pulmonary endothelium is especially sensitive to hyperoxic damage (43) . Indeed, pulmonary endothelial cells are the first cells damaged despite the exposure of the alveolar epithelium to similar 02 tensions (43) . It appears that the endothelium may be a particular risk to oxygen-dependent damage regardless of the oxidant source. Studies to determine the susceptibility of other vascular tissues to H202 and the biochemical nature of the endothelium's sensitivity to this oxidant are underway.
